Decreased availability of nitric oxide and hydrogen sulfide is a hallmark of COVID-19

被引:67
作者
Dominic, Paari [1 ,2 ,3 ]
Ahmad, Javaria [1 ]
Bhandari, Ruchi [4 ]
Pardue, Sibile [5 ]
Solorzano, Juan [1 ]
Jaisingh, Keerthish [1 ]
Watts, Megan [1 ,2 ,3 ]
Bailey, Steven R. [1 ,3 ]
Orr, A. Wayne [2 ,3 ,5 ,6 ]
Kevil, Christopher G. [2 ,3 ,5 ,6 ]
Kolluru, Gopi K. [3 ,5 ]
机构
[1] Louisiana State Univ, Hlth Sci Ctr, Dept Med, Shreveport, LA 71105 USA
[2] Louisiana State Univ, Hlth Sci Ctr, Mol & Cellular Physiol, Shreveport, LA 71105 USA
[3] Louisiana State Univ, Hlth Sci Ctr, Ctr Excellence Cardiovasc Dis & Sci, Shreveport, LA 71105 USA
[4] West Virginia Univ, Sch Publ Hlth, Dept Epidemiol, Morgantown, WV 26506 USA
[5] Louisiana State Univ, Hlth Sci Ctr, Dept Pathol, Shreveport, LA 71105 USA
[6] Louisiana State Univ, Hlth Sci Ctr, Cellular Biol & Anat, Shreveport, LA 71105 USA
基金
美国国家卫生研究院;
关键词
SARS-CoV-2; COVID-19; Nitric oxide; Hydrogen sulfide; Gasotransmitters; Cardiovascular disease; ACUTE RESPIRATORY SYNDROME; H2S; EXPRESSION; GROWTH; PLAYER; NO;
D O I
10.1016/j.redox.2021.101982
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is involved in a global outbreak affecting millions of people who manifest a variety of symptoms. Coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 is increasingly associated with cardiovascular complications requiring hospitalizations; however, the mechanisms underlying these complications remain unknown. Nitric oxide (NO) and hydrogen sulfide (H2S) are gasotransmitters that regulate key cardiovascular functions. Methods: Blood samples were obtained from 68 COVID-19 patients and 33 controls and NO and H2S metabolites were assessed. H2S and NO levels were compared between cases and controls in the entire study population and subgroups based on race. The availability of gasotransmitters was examined based on severity and outcome of COVID-19 infection. The performance of H2S and NO levels in predicting COVID-19 infection was also analyzed. Multivariable regression analysis was performed to identify the effects of traditional determinants of gasotransmitters on NO and H2S levels in the patients with COVID-19 infection. Results: Significantly reduced NO and H2S levels were observed in both Caucasian and African American COVID19 patients compared to healthy controls. COVID-19 patients who died had significantly higher NO and H2S levels compared to COVID-19 patients who survived. Receiver-operating characteristic analysis of NO and H2S metabolites in the study population showed free sulfide levels to be highly predictive of COVID-19 infection based on reduced availability. Traditional determinants of gasotransmitters, namely age, race, sex, diabetes, and hypertension had no effect on NO and H2S levels in COVID-19 patients. Conclusion: These observations provide the first insight into the role of NO and H2S in COVID-19 infection, where their low availability may be a result of reduced synthesis secondary to endotheliitis, or increased consumption from scavenging of reactive oxygen species.
引用
收藏
页数:12
相关论文
共 44 条
[1]   Mitigation of the replication of SARS-CoV-2 by nitric oxide in vitro [J].
Akaberi, Dario ;
Krambrich, Janina ;
Ling, Jiaxin ;
Luni, Chen ;
Hedenstierna, Goran ;
Jarhult, Josef D. ;
Lennerstrand, Johan ;
Lundkvist, Ake .
REDOX BIOLOGY, 2020, 37
[2]   Nitric oxide and virus infection [J].
Akaike, T ;
Maeda, H .
IMMUNOLOGY, 2000, 101 (03) :300-308
[3]   Nitric oxide inhibits the replication cycle of severe acute respiratory syndrome coronavirus [J].
Åkerström, S ;
Mousavi-Jazi, M ;
Klingström, J ;
Leijon, M ;
Lundkvist, Å ;
Mirazimi, A .
JOURNAL OF VIROLOGY, 2005, 79 (03) :1966-1969
[4]   Dual effect of nitric oxide on SARS-CoV replication: Viral RNA production and palmitoylation of the S protein are affected [J].
Akerstrom, Sara ;
Gunalan, Vithiagaran ;
Keng, Choong Tat ;
Tan, Yee-Joo ;
Mirazimi, Ali .
VIROLOGY, 2009, 395 (01) :1-9
[5]   Application of methylene blue -vitamin C -N-acetyl cysteine for treatment of critically ill COVID-19 patients, report of a phase-I clinical trial [J].
Alamdari, Daryoush Hamidi ;
Moghaddam, Ahmad Bagheri ;
Amini, Shahram ;
Keramati, Mohammad Reza ;
Zarmehri, Azam Moradi ;
Alamdari, Aida Hamidi ;
Damsaz, Mohammadamin ;
Banpour, Hamed ;
Yarahmadi, Amir ;
Koliakos, George .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2020, 885
[6]   Home Nitric Oxide Therapy for COVID-19 [J].
Alvarez, Roger A. ;
Berra, Lorenzo ;
Gladwin, Mark T. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 202 (01) :16-20
[7]   Hydrogen Sulfide: A Novel Player in Airway Development, Pathophysiology of Respiratory Diseases, and Antiviral Defenses [J].
Bazhanov, Nikolay ;
Ansar, Maria ;
Ivanciuc, Teodora ;
Garofalo, Roberto P. ;
Casola, Antonella .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2017, 57 (04) :403-410
[8]   Cytokine Storm in COVID-19-Immunopathological Mechanisms, Clinical Considerations, and Therapeutic Approaches: The REPROGRAM Consortium Position Paper [J].
Bhaskar, Sonu ;
Sinha, Akansha ;
Banach, Maciej ;
Mittoo, Shikha ;
Weissert, Robert ;
Kass, Joseph S. ;
Rajagopal, Santhosh ;
Pai, Anupama R. ;
Kutty, Shelby .
FRONTIERS IN IMMUNOLOGY, 2020, 11
[9]   Inhalation of nitric oxide in the treatment of severe acute respiratory syndrome: A rescue trial in Beijing [J].
Chen, LN ;
Liu, P ;
Gao, H ;
Sun, B ;
Chao, DS ;
Wang, F ;
Zhu, YJ ;
Hedenstierna, R ;
Wang, CG .
CLINICAL INFECTIOUS DISEASES, 2004, 39 (10) :1531-1535
[10]  
Chen T, 2020, BMJ-BRIT MED J, V368, DOI [10.1136/bmj.m1091, 10.1136/bmj.m1295]